Search Results 51-60 of 17383 for colitis

  1. Balsalazide (oral route) - Mayo Clinic

    Balsalazide capsules are used to treat mild to moderately active ulcerative colitis in patients 5 years of age and older. Balsalazide tablets are used to treat ...

  2. Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of trichuris suis ova (TSO) in ulcerative colitis (UC). We will look at how TSO affects ...

  3. Ulcerative colitis - Doctors and departments - Mayo Clinic

    This type of inflammatory bowel disease affects the innermost lining of your digestive tract. Learn about available treatments for this often exhausting ...

  4. A Study of the Relationship Between Infliximab Levels and the Rate of Colectomies in Patients who have Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to assess if infliximab drug levels in patients who have Ulcerative Colitis predict the risk of needing a colectomy. Additionally, ...

  5. Inflammatory Bowel Disease Diagnoses Rising - Mayo Clinic News Network

    A close family member diagnosed with ulcerative colitis as a child inspired Dr. Loftus' career focus. He became a gastroenterologist to be able to provide the ...

  6. Pediatric Inflammatory Bowel Disease Clinic - Mayo Clinic Children's Center

    Pediatric specialists provide cutting-edge treatment for children with ibd, including those with ulcerative colitis, Crohn's disease and other disorders.

  7. Probiotics Preventing Immune Checkpoint Inhibitor-Induced Colitis - Mayo Clinic

    To evaluate the incidence of immune checkpoint inhibitors (ICI)-induced colitis (IIC) in patients with solid malignancies receiving over-the-counter multi- ...

  8. Lifestyle and Diet in Inflammatory Bowel Disease - Mayo Clinic News Network

    Inflammatory bowel disease (IBD), which consists of Crohn's disease and ulcerative colitis, can be a frustrating diagnosis to deal with. In general, there ...

  9. Head-to-head comparison between vedolizumab and adalimumab for treatment of moderately to severely active ulcerative colitis - Mayo Clinic

    The Food and Drug Administration approved the use of anti-tumor necrosis factor and anti-integrin agents for the treatment of ulcerative colitis in 2005 ...

  10. Mesalamine (rectal route) - Mayo Clinic

    Mesalamineenema is used to treat active mild to moderate ulcerative colitis, proctitis or proctosigmoiditis (inflammation of the rectum and bowel). It works ...